TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

Identification of Taro-Lisdexamfetamine Chewable Tablets

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02533367

Dosage form(s): TABLET (CHEWABLE)

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TARO PHARMACEUTICALS INC

Date: 04-JUN-2024

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
• N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
• N06BA12 — LISDEXAMFETAMINE (ATC/DDD)

Reference brand drug: Vyvanse

External Links for Taro-Lisdexamfetamine Chewable Tablets

Search on Google

• Taro-Lisdexamfetamine Chewable Tablets side effects
• Taro-Lisdexamfetamine Chewable Tablets dosage
• lisdexamfetamine dimesylate side effects
• lisdexamfetamine dimesylate dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-lisdexamfetamine chewable tablets photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.